Cardiology resident and scientific associate with a PhD in translational research, combining clinical work with academic and scientific engagement. Particularly interested in intensive cardiology and heart failure, with a strong foundation in medical education and research integrity. Author of numerous peer-reviewed publications in heart failure, clinical trial methodology, and bioethics. Recognized with multiple international awards for scientific presentations and actively involved in collaborative cardiovascular research across European networks. Committed to advancing patient care through ethical, evidence-based medicine and academic excellence.
Glucagon-like peptide-1 receptor agonists and sodium glucose cotransporter-2 inhibitors combination therapy after acute myocardial infarction in patients with type 2 diabetes mellitus: a dynamic duo
Event:
ESC Congress 2025
Topic:
Pharmacotherapy
Session:
Pharmacotherapy in coronary artery disease (2)
The role of C-reactive protein-albumin and red blood cell distribution width to albumin level ratio change in patients with heart failure in the SGLT2 era
Event:
ESC Congress 2025
Topic:
Biomarkers
Session:
Diagnosis and biomarkers of heart failure